Composition
- Active ingredients
- RANOLAZINE 500MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RANOLAZINE 1GM · Tablet, extended releaseANDA210188-002 · Prescription
- RANOLAZINE 500MG · Tablet, extended releaseANDA210188-001 · Prescription
- RANOLAZINE 1GM · Tablet, extended releaseANDA210482-002 · Discontinued
- RANOLAZINE 500MG · Tablet, extended releaseANDA210482-001 · Discontinued
- RANOLAZINE 1GM · Tablet, extended releaseANDA211082-002 · Prescription
- RANOLAZINE 500MG · Tablet, extended releaseANDA211082-001 · Prescription
- RANOLAZINE 500MG · Tablet, extended releaseANDA211707-001 · Discontinued
- RANOLAZINE 1GM · Tablet, extended releaseANDA211707-002 · Discontinued
- RANOLAZINE 500MG · Tablet, extended releaseANDA209081-001 · Prescription
- RANOLAZINE 1GM · Tablet, extended releaseANDA209081-002 · Prescription
- RANOLAZINE 1GM · Tablet, extended releaseANDA209953-002 · Prescription
- RANOLAZINE 500MG · Tablet, extended releaseANDA209953-001 · Prescription
- RANOLAZINE 500MG · Tablet, extended release
At a glance
- Brand name
- Ranolazine
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Cipla
- Status
- Discontinued
- FDA approval
- 28 May 2019
- Application
- ANDA211291-001